22nd Century - Hemp and hops: Two of our favorite things
22nd Century Group (XXII) is poised to benefit from a growing cannabis market and increased demand by cultivators for higher-yielding crops. The upcoming harvest, additional plant lines in 2022–23 and strategic partnerships should boost revenues and accelerate the commercialization of the company’s improved hemp/cannabis lines. Moreover, XXII’s recently announced entry into the less-regulated hops market significantly expands its total addressable market as it leverages its intellectual property (IP) and scale to increase product speed to market.22nd Century Group is a plant biotechnology company focused on technology that allows the company to alter the level of nicotine and other nicotinic alkaloids in tobacco plants and the levels of cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. The company's products include:Very Low Nicotine Content Cigarettes, which contains less nicotine to reduce smokers' exposure to nicotine, which is the primary addictive component of cigarettes under the product names of Moonlight? and Moonlight Menthol?; and SPECTRUM? Government Research Cigarettes, which supplies cigarettes with different nicotine contents (from very low to high) to National Institute on Drug Abuse.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.